Search Results - "Aurora, SK"

Refine Results
  1. 1

    Periaqueductal Gray Matter Dysfunction in Migraine: Cause or the Burden of Illness? by Welch, K.M.A., Nagesh, Vijaya, Aurora, Sheena K., Gelman, Neil

    Published in Headache (01-07-2001)
    “…Objective.—The periaqueductal gray matter (PAG) is at the center of a powerful descending antinociceptive neuronal network. We studied iron homeostasis in the…”
    Get full text
    Journal Article
  2. 2

    The brain is hyperexcitable in migraine by Aurora, S K, Wilkinson, F

    Published in Cephalalgia (01-12-2007)
    “…Migraine is a very common disorder occurring in 20% of women and 6% of men. Central neuronal hyperexcitability is proposed to be the putative basis for the…”
    Get more information
    Journal Article
  3. 3

    OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial by Diener, H C, Dodick, D W, Aurora, S K, Turkel, C C, DeGryse, R E, Lipton, R B, Silberstein, S D, Brin, M F

    Published in Cephalalgia (01-07-2010)
    “…This is the second of a pair of studies designed to evaluate the efficacy and safety of onabotulinumtoxinA (BOTOX) for prophylaxis of headaches in adults with…”
    Get more information
    Journal Article
  4. 4

    OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial by Aurora, S K, Dodick, D W, Turkel, C C, DeGryse, R E, Silberstein, S D, Lipton, R B, Diener, H C, Brin, M F

    Published in Cephalalgia (01-07-2010)
    “…This is the first of a pair of studies designed to assess efficacy, safety and tolerability of onabotulinumtoxinA (BOTOX) as headache prophylaxis in adults…”
    Get more information
    Journal Article
  5. 5

    Intranasal sumatriptan in cluster headache: Randomized placebo-controlled double-blind study by VAN VLIET, J. A, BAHRA, A, MARTIN, V, RAMADAN, N, AURORA, S. K, MATHEW, N. T, FERRARI, M. D, GOADSBY, P. J

    Published in Neurology (25-02-2003)
    “…Current evidence-based acute treatments of cluster headache are limited to oxygen inhalation and subcutaneous sumatriptan. Intranasal sumatriptan is a new…”
    Get full text
    Journal Article
  6. 6

    A Real‐World Analysis of Migraine: A Cross‐Sectional Study of Disease Burden and Treatment Patterns by Ford, Janet H., Jackson, James, Milligan, Gary, Cotton, Sarah, Ahl, Jonna, Aurora, Sheena K.

    Published in Headache (01-11-2017)
    “…Objective The purpose of this cross‐sectional study was to assess the sociodemographics, disease burden, and treatment patterns of patients with episodic and…”
    Get full text
    Journal Article
  7. 7

    OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program by Dodick, David W., Turkel, Catherine C., DeGryse, Ronald E., Aurora, Sheena K., Silberstein, Stephen D., Lipton, Richard B., Diener, Hans-Christoph, Brin, Mitchell F.

    Published in Headache (01-06-2010)
    “…(Headache 2010;50:921‐936) Objective.— To assess the efficacy, safety, and tolerability of onabotulinumtoxinA (BOTOX®) as headache prophylaxis in adults with…”
    Get full text
    Journal Article
  8. 8

    The Occipital Cortex Is Hyperexcitable in Migraine: Experimental Evidence by Aurora, SK, Cao, Y., Bowyer, SM, Welch, K.M.A.

    Published in Headache (01-07-1999)
    “…Objectives.—Threshold for generation of magnetophosphenes has been reported to be lower in migraine. We compared the threshold for eliciting phosphenes by…”
    Get full text
    Journal Article
  9. 9
  10. 10

    OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program by Aurora, S. K., Dodick, D. W., Diener, H.-C., DeGryse, R. E., Turkel, C. C., Lipton, R. B., Silberstein, S. D.

    Published in Acta neurologica Scandinavica (01-01-2014)
    “…Objective Chronic migraine (CM) is a prevalent and disabling neurological disorder. Phase III REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT)…”
    Get full text
    Journal Article
  11. 11

    Clinical Characteristics and Treatment Patterns Among Patients Diagnosed With Cluster Headache in U.S. Healthcare Claims Data by Choong, Casey K., Ford, Janet H., Nyhuis, Allen W., Joshi, Shivang G., Robinson, Rebecca L., Aurora, Sheena K., Martinez, James M.

    Published in Headache (01-10-2017)
    “…Objective To characterize demographics, clinical characteristics, and treatment patterns of patients with cluster headache (CH). Background CH is an uncommon…”
    Get full text
    Journal Article
  12. 12

    Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications by Aurora, Sheena K, Papapetropoulos, Spyridon, Kori, Shashidhar H, Kedar, Archana, Abell, Thomas L

    Published in Cephalalgia (01-04-2013)
    “…Migraine is a disabling neurological disorder often complicated by gastrointestinal conditions such as gastric stasis. The association between migraine and…”
    Get more information
    Journal Article
  13. 13
  14. 14
  15. 15

    Is chronic migraine one end of a spectrum of migraine or a separate entity? by Aurora, S K

    Published in Cephalalgia (01-06-2009)
    “…Chronic migraine is associated with abnormalities in the periaqueductal grey that may be progressive. The condition is also associated with a greater degree of…”
    Get more information
    Journal Article
  16. 16

    Patient satisfaction, health care resource utilization, and acute headache medication use with galcanezumab: results from a 12-month open-label study in patients with migraine by Ford, Janet H, Foster, Shonda A, Stauffer, Virginia L, Ruff, Dustin D, Aurora, Sheena K, Versijpt, Jan

    Published in Patient preference and adherence (01-01-2018)
    “…Effects of galcanezumab, a monoclonal antibody against calcitonin gene-related peptide, on patient satisfaction, health care resource utilization (HCRU), and…”
    Get full text
    Journal Article
  17. 17

    Health Care Utilization and Direct Costs Among Patients Diagnosed with Cluster Headache in U.S. Health Care Claims Data by Choong, Casey K, Ford, Janet H, Nyhuis, Allen W, Robinson, Rebecca L, Aurora, Sheena K

    “…Cluster headache (CH) is a rare trigeminal cephalalgia that is associated with extremely painful unilateral headache attacks and autonomic symptoms. Attacks…”
    Get full text
    Journal Article
  18. 18

    Randomized, Controlled Study of Telcagepant in Patients With Migraine and Coronary Artery Disease by Ho, Tony W., Ho, Andrew P., Chaitman, Bernard R., Johnson, Constance, Mathew, Ninan T., Kost, James, Fan, Xiaoyin, Aurora, Sheena K., Brandes, Jan L., Fei, Kaiyin, Beebe, Louise, Lines, Christopher, Krucoff, Mitchell W.

    Published in Headache (01-02-2012)
    “…Objective.— To evaluate the efficacy of telcagepant in patients with migraine and coronary artery disease. Background.— Calcitonin gene‐related peptide…”
    Get full text
    Journal Article
  19. 19

    Functional MRI-BOLD of brainstem structures during visually triggered migraine by CAO, Y, AURORA, S. K, NAGESH, V, PATEL, S. C, WELCH, K. M. A

    Published in Neurology (09-07-2002)
    “…Previously, hyperoxia and blood volume increase were reported in the red nucleus and substantia nigra during spontaneous migraine with aura. To further…”
    Get full text
    Journal Article
  20. 20